Life Sciences Research to Product Development : Regulatory Requirement Transforming, Volume 1

個数:
電子版価格
¥11,320
  • 電子版あり

Life Sciences Research to Product Development : Regulatory Requirement Transforming, Volume 1

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 244 p.
  • 言語 ENG
  • 商品コード 9781032504261
  • DDC分類 615.19

Full Description

The present volume, Life Sciences Research to Product Development: Regulatory Requirement Transforming, Volume 1, discusses the procedures of drug approval and regulatory requirements that must be met according to the United States Food and Drug Administration (US FDA), the European Medical Agency (EMA), and the Central Drug Standard Control Organization (CDSCO). Many researchers either abandon their work in the middle of the process or find it difficult to follow the rules. Therefore, it is not surprising that any biological researcher associated with drug development should have a thorough understanding of regulatory requirements. This volume incorporates all the requisite regulatory norms and provides the latest information on the mandated regulation of herbal medicines.

The book covers other obligatory regulatory requirements such as:

The legal method and practice of herbal drug products, the roles of Ayurvedic medicines, and the process to obtain regulatory approval.
Drug molecules not included in Department of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and homeopathy (AYUSH) but referred to as phytopharmaceuticals are also considered new drugs.
The boundary line between food and herbal pharmaceuticals is discussed, as well as pre-clinical toxicity testing, clinical trials, and stability studies in accordance with the rules.

The chapter on regulatory implications for the approval process in this book will be the most useful resource for researchers and students, particularly those with backgrounds in pharma, forensic medicine, or regulatory affairs, or those who aspire to succeed in drug research. Additionally, the information contained in this volume of the book could be of great interest to researchers working in the herbal drug industry.

Contents

Chapter 1: Process of Drug Discovery

Chapter 2: History of Drug Regulatory Authorities

Chapter 3: Regulatory of Herbal and Ayurvedic Drug in the context of AYUSH and DCGI

Chapter 4: Traditional medicine (TM)- Regulatory Requirement

Chapter 5: Enforcement of Drug & Cosmetics Act, 1940 to Ayurvedic and Unani Drugs in India

Chapter 6: Ayurvedic Drugs Regulation in India

Chapter 7: Licensing procedure of Indian System of medicine (Ayurveda, Unani, Siddha and Homoeopathy Drugs)

Chapter 8: Regulatory Approval Process of Phytopharmaceuticals, Herbal Drugs or Isolated Compounds from plants or New Claim other than AYUSH Drugs

Chapter 9: Safety and toxicity of Ayurveda, Siddha and Unani (ASU) drugs

Chapter 10: The embarking of Food Safety and Standards Authority of India (FSSAI) and implantation of Food Safety and Standards Act

Chapter-11: Herbal as food vs Drugs: Regulatory framework

Chapter 12: Regulatory Approval and Commercialization process herbal as Insecticide

Chapter 13: Safety studies or pre-clinical toxicity of Modern Medicine

Chapter 14: Clinical trial procedures including the modern medicine and ayurvedic therapies

Chapter 15: Stability Testing of Drugs

Chapter 16: Regulation of Clinical Trial and Role of Institutional Human Ethical Committee

最近チェックした商品